Skip to main content
. Author manuscript; available in PMC: 2023 Jan 10.
Published in final edited form as: Cancer Cell. 2021 Dec 23;40(1):26–35. doi: 10.1016/j.ccell.2021.12.004

Table 1.

Companies conducting FPM services

Company Location FPM assay(s)
2CureX Copenhagen, Denmark patient tumor ex vivo assays
Allcyte Vienna, Austria patient tumor ex vivo assays
Celcuity Minnesota, USA patient tumor ex vivo assays
Cellesce Cardiff, Wales patient tumor ex vivo assays
Certis California, USA PDX
Champions New Jersey, USA PDX
Crown Bio California, USA patient tumor ex vivo assays
Imprimed California, USA veterinary ex vivo assays
Kibur Medical Massachusetts, USA implantable drug delivery microdevice
Knownmed Utah, USA patient tumor ex vivo assays
Nagourney Cancer Institute California, USA patient tumor ex vivo assays
Notable Labs California, USA patient tumor ex vivo assays
Presage Bio Washington, USA implantable drug delivery microdevice
SageMedic California, USA patient tumor ex vivo assays
SEngine Washington, USA patient tumor ex vivo assays
SpeciCare Georgia, USA patient sample provider
Tempus Chicago, IL patient tumor ex vivo assays
Travera Massachusetts, USA suspended microchannel resonator
Vivia Biotech Madrid, Spain patient tumor ex vivo assays